Mounjaro 15 mg
  1. Home
  2. Mounjaro
  3. Mounjaro 15 mg

Mounjaro 15 mg

Mounjaro 15 mg is a prescription dual GIP and GLP-1 receptor agonist used to improve glycemic control in adults with type 2 diabetes and, for certain formulations, to support chronic weight management. It is administered as a once-weekly subcutaneous injection using a sterile prefilled injection pen. The 15 mg strength is commonly prescribed as the highest maintenance dose for eligible patients according to the prescribed treatment plan.

BUY NOW

Category

Mounjaro 15 mg contains tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood glucose and body weight by enhancing glucose-dependent insulin secretion, reducing glucagon release, slowing gastric emptying, and promoting satiety. The 15 mg maintenance dose is typically prescribed after gradual dose escalation when additional therapeutic benefit is clinically appropriate. Manufactured under stringent pharmaceutical quality standards, the sterile prefilled injection pen is engineered for precise subcutaneous administration and dependable clinical performance across long-term treatment. Mounjaro 15 mg should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Mounjaro 15 mg
Active Ingredient Tirzepatide
Strength 15 mg
Dosage Form Sterile Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Mounjaro 15 mg, Tirzepatide 15 mg, Mounjaro Injection Pen, Tirzepatide Prefilled Pen, Weekly Tirzepatide Injection, GIP GLP-1 Receptor Agonist, Diabetes Injection Pen